GlassScriptPhysician profile
Randall W Viola
NPI 1003861931
$550,572.96
in general payments reported to CMS, 2019-2025
7 companies · $106K in 2025
The $106K reported for 2025 was more than what 97% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67K · 2020: $51K · 2021: $78K · 2022: $57K · 2023: $104K · 2024: $89K · 2025: $106K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $299K · Food and Beverage: $73.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $298,512.68 |
| Food and Beverage | $73.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $452,423.29 | 2019-2025 | Trueshot |
| Osteomed LLC | $50,669.01 | 2019-2021 | |
| Acumed LLC | $47,163.20 | 2023-2025 | Osteomed |
| Arthrex, INC. | $194.11 | 2021 | |
| Medartis INC. | $52.50 | 2025 | Aptus |
| Bioventus LLC | $46.36 | 2021-2023 | Exogen Ultrasound Bone Healing System |
| Integra Lifesciences Corporation | $24.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Viola listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.